{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:55:09Z","timestamp":1777874109438,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2023HXFH037"],"award-info":[{"award-number":["2023HXFH037"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200695"],"award-info":[{"award-number":["82200695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpainsymman.2025.07.034","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:23:21Z","timestamp":1756250601000},"page":"557-568.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palonosetron Plus Megestrol Acetate Versus Palonosetron Plus Dexamethasone in Preventing Moderately Emetogenic Chemotherapy-induced Nausea and Vomiting: A Randomized, Multicenter, Crossover Trial"],"prefix":"10.1016","volume":"70","author":[{"given":"Qiaoqi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhe","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfeng","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jpainsymman.2025.07.034_bib0001","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","article-title":"Overview and countermeasures of cancer burden in China","volume":"66","author":"Wang","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"13","key":"10.1016\/j.jpainsymman.2025.07.034_bib0002","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.7150\/thno.57828","article-title":"Recent progress in nanomedicine for enhanced cancer chemotherapy","volume":"11","author":"Wei","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/cancers14030627","article-title":"Chemotherapy side-effects: not all DNA damage is equal","volume":"14","author":"van den Boogaard","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.07.034_bib0004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jnci\/93.11.810","article-title":"Behavioral intervention for cancer treatment side effects","volume":"93","author":"Redd","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.jpainsymman.2025.07.034_bib0005","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1007\/s00432-023-04630-4","article-title":"Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review","volume":"149","author":"Lattard","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2025.07.034_bib0006","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/14656566.2013.776541","article-title":"Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients","volume":"14","author":"Janelsins","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"17","key":"10.1016\/j.jpainsymman.2025.07.034_bib0007","article-title":"Effectively managing chemotherapy-induced nausea and vomiting","volume":"20","author":"Middleton","year":"2011","journal-title":"Br J Nurs"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end\u2013patient perception of the side-effects of cancer chemotherapy","volume":"19","author":"Coates","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.034_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0012-3692(16)34418-X","article-title":"Megestrol complications","volume":"123","author":"Bennett","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.034_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0305-7372(89)90004-2","article-title":"Megestrol acetate: clinical experience","volume":"16","author":"Schacter","year":"1989","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.034_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2003.11.008","article-title":"Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Fiorica","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.jpainsymman.2025.07.034_bib0012","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1200\/JCO.2007.14.5029","article-title":"Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial","volume":"26","author":"Ravaud","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0013","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000421-199706000-00021","article-title":"Megestrol acetate in the treatment of hormone refractory prostate cancer","volume":"20","author":"Osborn","year":"1997","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004310.pub2","article-title":"Megestrol acetate for the treatment of anorexia-cachexia syndrome","volume":"18","author":"Berenstein","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0015","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"2013","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jpainsymman.2025.07.034_bib0016","first-page":"667","article-title":"Antiemetic activity of megestrol acetate in patients receiving chemotherapy","volume":"19","author":"Zang","year":"2011","journal-title":"Support Care Cancer"},{"issue":"20","key":"10.1016\/j.jpainsymman.2025.07.034_bib0017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.21037\/atm-22-4809","article-title":"Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study","volume":"10","author":"Ma","year":"2022","journal-title":"Ann Transl Med"},{"issue":"18 Suppl","key":"10.1016\/j.jpainsymman.2025.07.034_bib0018","first-page":"S391","article-title":"Overview of the prevention and management of CINV","volume":"24","author":"Natale","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jpainsymman.2025.07.034_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/595894","article-title":"Treatment of breakthrough and refractory chemotherapy-induced nausea and vomiting","volume":"2015","author":"Navari","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.034_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference","volume":"17","author":"Roila","year":"2006","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.jpainsymman.2025.07.034_bib0021","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1200\/JCO.2007.15.9533","article-title":"Evidence-based recommendations for cancer nausea and vomiting","volume":"26","author":"Naeim","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.07.034_bib0022","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjc.1997.507","article-title":"Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists","volume":"76","author":"de Boer-Dennert","year":"1997","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","article-title":"Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial","volume":"10","author":"Saito","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jpainsymman.2025.07.034_bib0024","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.18632\/oncotarget.14135","article-title":"Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Kr\u00fcppel-like factor 5 in triple-negative breast cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jpainsymman.2025.07.034_bib0025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.1992.tb09077.x","article-title":"Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor","volume":"105","author":"Filep","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"6449","key":"10.1016\/j.jpainsymman.2025.07.034_bib0026","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/bmj.289.6449.878-a","article-title":"Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting","volume":"289","author":"Allan","year":"1984","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0027","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2","article-title":"Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients","volume":"55","author":"Kris","year":"1985","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jpainsymman.2025.07.034_bib0028","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjc.6603048","article-title":"Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy","volume":"94","author":"Vardy","year":"2006","journal-title":"Br J Cancer"},{"issue":"8488","key":"10.1016\/j.jpainsymman.2025.07.034_bib0029","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(86)91305-X","article-title":"Dexamethasone antiemesis and side-effects","volume":"1","author":"Allan","year":"1986","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jpainsymman.2025.07.034_bib0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(11)70153-X","article-title":"Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial","volume":"12","author":"Chochinov","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0031","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1470-2045(19)30678-3","article-title":"Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Hashimoto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2025.07.034_bib0032","unstructured":"National Cancer Institute, Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 U.S. Department of Health and Human Services, 2017.https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5\u00d77.pdf."},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpainsymman.2006.10.018","article-title":"Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool","volume":"34","author":"Molassiotis","year":"2007","journal-title":"J Pain Sympt Manage"},{"issue":"5","key":"10.1016\/j.jpainsymman.2025.07.034_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jpainsymman.2025.07.034_bib0035","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1634\/theoncologist.2019-0292","article-title":"Multicenter registry study of antiemesis for carboplatin-based chemotherapy-induced nausea and vomiting in Japan","volume":"25","author":"Iihara","year":"2020","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jpainsymman.2025.07.034_bib0036","first-page":"107","article-title":"Aaronson NK: chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study","volume":"20","author":"Hilarius","year":"2012","journal-title":"Supp Care Can"},{"issue":"6","key":"10.1016\/j.jpainsymman.2025.07.034_bib0037","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/cas.12146","article-title":"Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis","volume":"104","author":"Sekine","year":"2013","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0038","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jcsm.12292","article-title":"Megestrol acetate for cachexia-anorexia syndrome. a systematic review","volume":"9","author":"Ruiz-Garc\u00eda","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.jpainsymman.2025.07.034_bib0039","first-page":"497","article-title":"Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings","volume":"15","author":"Cohen","year":"2007","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.jpainsymman.2025.07.034_bib0040","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jpainsymman.2025.07.034_bib0041","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/cncr.11408","volume":"97","author":"Hickok","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jpainsymman.2025.07.034_bib0042","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/cncr.22823","article-title":"Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy","volume":"110","author":"Tina Shih","year":"2007","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jpainsymman.2025.07.034_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2024.102077","article-title":"Corticosteroid therapy in older adults with cancer: expert recommendations from a task force of the International Society of Geriatric Oncology","volume":"16","author":"Bartsch","year":"2025","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jpainsymman.2025.07.034_bib0044","doi-asserted-by":"crossref","first-page":"i68","DOI":"10.1093\/bja\/aet577","article-title":"Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial","volume":"113 Suppl 1","author":"Singh","year":"2014","journal-title":"Br J Anaesth"},{"issue":"12","key":"10.1016\/j.jpainsymman.2025.07.034_bib0045","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.7326\/0003-4819-110-12-1034_2","article-title":"Megestrol acetate and hyperpnea","volume":"110","author":"Fessel","year":"1989","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jpainsymman.2025.07.034_bib0046","first-page":"466","article-title":"Observation on therapeutic effect of megestrol acetate on patients with chronic obstructive pulmonary disease at remission stage","volume":"35","author":"Qin","year":"1996","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.jpainsymman.2025.07.034_bib0047","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1378\/chest.121.4.1070","article-title":"Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients","volume":"121","author":"Weisberg","year":"2002","journal-title":"Chest"},{"issue":"2\u20133","key":"10.1016\/j.jpainsymman.2025.07.034_bib0048","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1569-9048(03)00086-7","article-title":"Sex steroid hormones and the neural control of breathing","volume":"136","author":"Behan","year":"2003","journal-title":"Respir Physiol Neurobiol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242500764X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242500764X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:05:23Z","timestamp":1777575923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539242500764X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S088539242500764X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.07.034","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palonosetron Plus Megestrol Acetate Versus Palonosetron Plus Dexamethasone in Preventing Moderately Emetogenic Chemotherapy-induced Nausea and Vomiting: A Randomized, Multicenter, Crossover Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}